Advance Nuclear Diagnostic and Therapeutic Centre

Overview

Established in 2018, the Advance Nuclear Diagnostic and Therapeutic Centre @ PHKL is equipped with cutting-edge advanced technology in Nuclear Medicine (PET-CT & SPECT-CT) to deliver accurate structural and functional imaging of the body for diagnosis and management of cancer and other diseases. This allows for tailored individualised treatment plans for our patients, which translate to better prognosis and outcomes for our patients.

Nuclear Medicine is a branch of medical imaging, which uses a small amount of radioactive substance injected into the body, inhaled or swallowed, to diagnose and treat a variety of diseases including cancers, gastrointestinal, heart disease, endocrine and neurological disorder. It is often able to identify abnormalities very early in the progression of a disease, long before many medical problems are apparent with other diagnostic tests.

After diagnosis, and when treatment starts, these scans continue to play an important role in monitoring its effects and progress of treatment regime, to determine if modification of therapy is required.

Diagnostic Services

Siemens Biograph mCT S 64 PET-CT

The Siemens Biograph mCT S 64 is a whole-body PET/CT tomograph machine designed for the purposes of oncological, neurological and cardiac imaging and diagnosis. This machine has high spatial slice resolution and high sensitivity detector for faster acquisition. It is also capable of scanning the entire body in one scan with long scan range of 203cm. With TrueV technology, it widens axial field of view (FOV) and increases count rate performance. This enables scan time to be shortened for faster imaging process.

The CT imaging capability of the Biograph mCT consists of a 64 slice CT. Thus, it offers full range spiral CT application. The machine also supports advanced RT simulation to further enhance accurate localisation of tumours. This advanced technology utilises fluorodeoxyglucose (F-18 FDG) to visualise the molecular function of active diseased cells, cancer in particular and its spread throughout the whole body. PET-CT is commonly used in cancer diagnosis as to its capability improving the cancer staging accuracy thus becoming the best modality in monitoring the progress of cancer treatment. The device is also proven to benefit patient diagnosed with Coronary Artery Diseases and with peripheral arteries including dementia especially Alzheimer Disease. The New 4-D PET-CT technology with respiratory gating allow an accurate assessment for treatment.

Besides the F-18 FDG, the machine also performs Ga-68 DOTATATE and PSMA PET-CT Scan – a radiopharmaceutical tracer used during PET Scans for prostate cancer and neuroendocrine tumour respectively. The Ga-68 DOTATE PET-CT full-body scan can capture neuroendocrine tumours (NETs) that overexpress somatostatin receptors and show where the tumours are located in the body.  Ga-68 PSMA PET-CT full-body scan is a modern diagnostic imaging procedure and becoming the gold standard in the diagnosis of prostate cancer. It is able to bind prostate tumour cells to be imaged using the PET technique. This technique also helps to monitor prostate cancer metastasis and recurrence even at low levels of PSA.

Siemens Symbia Intevo T16 SPECT-CT

The Siemens Symbia Intevo T16 SPECT/CT is a combination of state-of-the-art Single Photon Emission Computed Tomography (SPECT) and high quality 16 slices diagnostic Computed Tomography (CT). With xSPECT technology, true integration of SPECT and CT images are enabled. Together with HD detector, it allows SPECT information to be registered into CT frame of reference resulting in higher SPECT images resolution and accurate, reproducible quantitative results. This machine can operate as SPECT-only, SPECT-CT or stand-alone CT diagnostic application.

The role of SPECT in showing biological functions through radio-tracer distribution in the body and when combined with CT modality showing precise location and anatomical structures making this advanced technology a superior diagnostic imaging modality than other conventional diagnostic imaging. The functional imaging produced by SPECT-CT includes whole body bone scintigraphy, thyroid scintigraphy, parathyroid scintigraphy, myocardial perfusion and heart function scintigraphy, gastrointestinal (GIT) bleed scintigraphy, renal scintigraphy, hepatobiliary scan, lung scintigraphy, brain scintigraphy, etc.

Other Diagnostic Services

Nuclear Medicine services include not only diagnostics tool but also therapy facilities which consist of:
• Iodine I-131 Therapy for Thyroid Cancer
• Iodine I-131 Therapy for Thyrotoxicosis
• Lutetium Lu-177 Therapy PSMA for Prostate Cancer
• Lutetium Lu-177 Therapy DOTATATE for Neuroendocrine Cancer
• Gallium-68 PSMA PET-CT Scan for Prostate Cancer
• Gallium-68 DOTATATE PET-CT Scan for Neuroendocrine Cancer
• Samarium SM-153 EDTMP for Pain Bone Metastases
• Yttrium Y-90 Thera Sphere for Hepatocellular Carcinoma (HCC)

For more information please contact our Advance Nuclear Diagnostic and Therapeutic Centre:

Tel : +603-2296 0942 / 4
Email : [email protected]